MeSH D003556 - cystitis
Favorite
Competitive Landscape
Events Timeline
Commercial
Clinical Trials
Competitive landscape
D001745:Urinary bladder diseases
D003556:
Cystitis
D053653:Pyelocystitis
0 Companies
0 Drugs
Success rate
D000096722:Hemorrhagic cystitis
0 Companies
0 Drugs
Success rate
Events Timeline
Commercial
Company Name | Drug Name | Trade Name | Patent Expires | Approval Date | Revenue | Period |
|---|---|---|---|---|---|---|
| ALK-Abelló | Ciprofloxacin | Otiprio | 2029-04-21 | 2015-12-10 | ||
| Alkem Laboratories | Cefpodoxime proxetil | Cefpodoxime Proxetil | 2022-05-18 | |||
| Allergan | Ofloxacin | Ocuflox | 1993-07-30 | |||
| Ciprofloxacin | Ciprofloxacin | 2005-01-21 | ||||
| Altaire Pharmaceuticals | Ciprofloxacin | Ciprofloxacin | 2018-05-03 | |||
| Ofloxacin | Ofloxacin | 2013-04-29 | ||||
| Alvogen | Ofloxacin | Ofloxacin | 2004-08-31 | |||
| Methenamine hippurate | Urex | 1982-01-01 | ||||
| Amneal Pharmaceuticals | Ciprofloxacin | Ciprofloxacin | 2004-06-09 | |||
| Ofloxacin | Ofloxacin | 2019-08-30 |
1
2
3
4
5
6
...
9
>
Clinical Trials
Historical Success Rate
Phase 1
0%0/0
Phase 2
67%2/3
Phase 3
100%12/12
Approved: 11Overall Success rate: 0%
All Clinical Trials
Therapeutic Areas:
All
Classification:
All
Approval:
All
Status:
All
Phases:
All
Company name | Phase 1 | Phase 2 | Phase 3 | Phase 4 | Drug Name |
|---|---|---|---|---|---|
1
2
3
4
5
6
>
© 2020-2025 Collaborative Drug Discovery Inc. (CDD) | Terms of Use